GlaxoSmithKline Consumer Nigeria PLC has been notified by GSK UK Group of its strategic plan to stop selling its prescription drugs and vaccines in Nigeria.

The company released this information via a formal statement that was sent to the Nigeria Exchange Limited and was signed by the company secretary, Frederick Ichekwai.

The company stated in its unaudited HY 2023 financial statement that it will designate a local Nigerian third-party distributor to handle the supply of its consumer healthcare products.

This is a developing story…